Disclaimer

The alfapump® system is currently not approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. DSR® therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.

Spontaneous applications

We are looking for talented individuals interested in joining an innovative, creative, dynamic and open-minded team.
To find out more information, please explore our job opportunities or complete the form below.


    (pdf, doc, docx; max size: 3Mb)

    I agree to the Sequana Medical Privacy Policy

    PRESS RELEASES

    SUBSCRIBE TO OUR PRESS RELEASES